For several years, researchers have been developing a new approach to treating cancer that uses viruses to infect and kill cancer cells while leaving normal cells unharmed. New research indicates that this approach, which is known as oncolytic virotherapy, can be combined with a standard clinical therapy to provide substantial regression and cure of tumors in mice, leading to the suggestion that this combinatorial approach could be of tremendous benefit in the clinic.